CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹899 Cr | ₹804 Cr | ₹786 Cr | ₹869 Cr | ₹706 Cr |
What is the latest Total Non-Current Assets ratio of CONCORD BIOTECH ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹899 Cr |
| Mar2024 | ₹804 Cr |
| Mar2023 | ₹786 Cr |
| Mar2022 | ₹869 Cr |
| Mar2021 | ₹706 Cr |
How is Total Non-Current Assets of CONCORD BIOTECH Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹899 Cr | 11.75 | |
| Mar2024 | ₹804 Cr | 2.31 | |
| Mar2023 | ₹786 Cr | -9.54 | |
| Mar2022 | ₹869 Cr | 23.19 | |
| Mar2021 | ₹706 Cr | - | |
Compare Total Non-Current Assets of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹11,757.0 Cr | -0.3% | 8.2% | -24.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,121.0 Cr | 3.2% | 12.5% | 10.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,396.0 Cr | 2.9% | 8.5% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,730.0 Cr | 0.3% | 5.7% | 36.3% | Stock Analytics | |
| CIPLA | ₹115,241.0 Cr | 10.4% | 15.9% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,126.0 Cr | 4.8% | 9% | 10.8% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -0.3% |
8.2% |
-24.7% |
| SENSEX | -0.9% |
-3.6% |
-8.6% |
You may also like the below Video Courses